| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |